SUITA, OSAKA PREF. –
Japanese researcher Shimon Sakaguchi, one of the three winners of this year’s Nobel Prize in physiology or medicine, has voiced hope to develop effective cancer immunotherapy using regulatory T cells he discovered.
In an interview ahead of the Nobel Prize award ceremony in Stockholm on Wednesday, Sakaguchi noted that the cells, which suppress excessive immune response, are being prepared for clinical application while challenges lie in creating immunity targeting cancer cells.
“We hope to reduce the possibility of metastases in the future,” he also said.
